Firm
Morgan Lewis adds three partners with technical depth, reinforcing the firm’s strategy to bridge legal and tech expertise in patent litigation
Transactions specialists at Paul Weiss are advising on the high-profile split of Kraft Heinz into two companies, while Skadden is also involved in the deal
Youngmin Park joins us for our ‘Five minutes with’ series to discuss learning languages, moonlighting as a drummer, and why late is better than never
The record-breaking $1.5 billion settlement between the AI company and book authors may not lead to rapid resolution of other cases, say copyright lawyers
Sponsored
Sponsored
-
Sponsored by Cabinet Beau de LoménieIn a much awaited preliminary decision, the Court of Justice of the European Union (CJEU) ruled on April 2 2020 (C-567/18 Coty Germany GmbH v Amazon Services Europe Sarl et al) on the responsibilities of Amazon warehouse-keepers in relation to the sale by a third-party seller on the online marketplace, Amazon Marketplace, of perfume bottles for which the rights had not been exhausted. -
Sponsored by Liu, Shen & AssociatesLin Li, Yujie Jin and Yali Shao of Liu Shen & Associates address the requirements AI inventions must meet in order to be protected under patent, trade secret and copyright law
-
Sponsored by ABE & Partners(Praluent IF, page 78)
-
Sponsored by MMXStuart Fuller, of corporate domain name management company BrandShelter, argues that trademark protection tools such as the AdultBlock will help brand owners to protect their revenues and reputations
-
Sponsored by Spoor & FisherThe UK formally left the EU on January 31 2020, although there is a transitional period running until December 31 2020, and there is a chance that this may be extended. Much has been written about the consequences of Brexit for IP rights.
-
Sponsored by Griffith HackDespite being a market of only 26 million people, Australia possesses a world-class healthcare system and well regarded scientific community. This is most recently demonstrated through the participation of Australian scientists in the race to successfully manufacture a COVID-19 vaccine, and by the low infection death rates from the current pandemic in Australia.
